12,133 Shares in Healthpeak Properties, Inc. (NYSE:DOC) Bought by Arjuna Capital

Arjuna Capital purchased a new position in shares of Healthpeak Properties, Inc. (NYSE:DOCFree Report) in the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 12,133 shares of the real estate investment trust’s stock, valued at approximately $277,000.

Several other institutional investors have also bought and sold shares of DOC. Sumitomo Mitsui Trust Group Inc. bought a new stake in Healthpeak Properties during the third quarter worth $102,615,000. abrdn plc bought a new stake in Healthpeak Properties during the third quarter worth $62,670,000. Douglas Lane & Associates LLC purchased a new position in Healthpeak Properties in the third quarter worth $33,947,000. Foresight Group Ltd Liability Partnership purchased a new position in Healthpeak Properties in the third quarter worth $33,212,000. Finally, Victory Capital Management Inc. purchased a new position in Healthpeak Properties in the third quarter worth $32,470,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

DOC traded up $0.26 during trading on Wednesday, reaching $22.05. 395,365 shares of the company were exchanged, compared to its average volume of 5,706,310. The company’s 50-day moving average is $22.32 and its two-hundred day moving average is $21.00. The company has a market cap of $15.42 billion, a price-to-earnings ratio of 46.32, a P/E/G ratio of 2.49 and a beta of 1.13. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93. Healthpeak Properties, Inc. has a 12-month low of $16.01 and a 12-month high of $23.26.

Healthpeak Properties (NYSE:DOCGet Free Report) last released its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.32). The business had revenue of $700.40 million during the quarter, compared to analysts’ expectations of $682.51 million. Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The business’s revenue was up 25.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.45 EPS. Research analysts forecast that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be paid a $0.30 dividend. The ex-dividend date is Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a yield of 5.44%. Healthpeak Properties’s dividend payout ratio is presently 255.32%.

Wall Street Analyst Weigh In

Several research firms have weighed in on DOC. Scotiabank boosted their price objective on Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a research report on Monday, September 9th. Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Wells Fargo & Company reissued an “equal weight” rating and issued a $23.00 price objective (up previously from $22.00) on shares of Healthpeak Properties in a research report on Tuesday, October 1st. Finally, Wedbush boosted their price objective on Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research report on Monday, July 29th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.86.

Read Our Latest Stock Report on Healthpeak Properties

Healthpeak Properties Company Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Read More

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOCFree Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.